$PALI
PALISADE BIO, INC.

2019 Q3 Form 10-Q Financial Statement

#000117184319005480 Filed on August 14, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 Q2 2018 Q4
Revenue $2.500K $7.894K $0.00
YoY Change 0.0% -96.87% -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.300M $970.0K $930.0K
YoY Change 9.24% -23.02% -28.46%
% of Gross Profit
Research & Development $825.5K $954.5K $880.0K
YoY Change -7.98% -5.94% -28.46%
% of Gross Profit
Depreciation & Amortization $30.00K $40.00K $30.00K
YoY Change -40.0% 0.0% -50.0%
% of Gross Profit
Operating Expenses $2.127M $1.926M $1.810M
YoY Change 1.99% -15.35% -28.17%
Operating Profit -$2.124M -$1.918M
YoY Change 1.99% -5.17%
Interest Expense $1.913K $507.00 $1.480M
YoY Change 27.7% -34.33% -240.95%
% of Operating Profit
Other Income/Expense, Net $361.0K $481.5K $0.00
YoY Change 43.05% -65.51% -100.0%
Pretax Income -$1.760M -$1.440M -$320.0K
YoY Change -3.83% 128.57% -90.36%
Income Tax
% Of Pretax Income
Net Earnings -$1.763M -$1.437M -$320.0K
YoY Change -3.67% 129.16% -90.36%
Net Earnings / Revenue -70525.36% -18202.7%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.520M -$8.471M -$2.462M
COMMON SHARES
Basic Shares Outstanding 2.100M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q3 2019 Q2 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.300M $2.280M $5.790M
YoY Change 27.18% -67.84% -50.39%
Cash & Equivalents $7.300M $2.281M $5.787M
Short-Term Investments $0.00
Other Short-Term Assets $610.0K $260.0K $360.0K
YoY Change 10.91% -23.53% -10.0%
Inventory
Prepaid Expenses $605.3K $256.8K $363.3K
Receivables $61.15K $169.9K $294.1K
Other Receivables $0.00 $0.00 $70.00K
Total Short-Term Assets $7.966M $2.708M $6.508M
YoY Change 22.44% -65.79% -47.72%
LONG-TERM ASSETS
Property, Plant & Equipment $51.94K $63.44K $90.31K
YoY Change -51.52% -50.44% -47.76%
Goodwill
YoY Change
Intangibles $688.1K $713.3K $763.5K
YoY Change -12.76% -12.38% -13.57%
Long-Term Investments
YoY Change
Other Assets $240.0K $36.90K $23.97K
YoY Change 742.84% 11.81% 73.0%
Total Long-Term Assets $977.2K $813.6K $1.176M
YoY Change -19.55% -38.28% -18.08%
TOTAL ASSETS
Total Short-Term Assets $7.966M $2.708M $6.508M
Total Long-Term Assets $977.2K $813.6K $1.176M
Total Assets $8.944M $3.522M $7.684M
YoY Change 15.83% -61.86% -44.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.180M $1.050M $830.0K
YoY Change 40.48% 47.89% -5.68%
Accrued Expenses $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.581M $1.071M $1.051M
YoY Change 33.49% 39.86% -30.6%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $320.0K $490.0K $580.0K
YoY Change -84.47% -78.6% -84.94%
Total Long-Term Liabilities $320.0K $490.0K $580.0K
YoY Change -84.47% -78.6% -84.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.581M $1.071M $1.051M
Total Long-Term Liabilities $320.0K $490.0K $580.0K
Total Liabilities $1.901M $1.559M $1.635M
YoY Change -41.36% -49.02% -69.55%
SHAREHOLDERS EQUITY
Retained Earnings -$219.9M -$218.2M -$213.6M
YoY Change 3.11% 3.17% 2.36%
Common Stock $28.18K $10.02K $9.103K
YoY Change -81.46% -93.39% -94.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.043M $1.963M $6.050M
YoY Change
Total Liabilities & Shareholders Equity $8.944M $3.522M $7.684M
YoY Change 15.83% -61.86% -44.65%

Cashflow Statement

Concept 2019 Q3 2019 Q2 2018 Q4
OPERATING ACTIVITIES
Net Income -$1.763M -$1.437M -$320.0K
YoY Change -3.67% 129.16% -90.36%
Depreciation, Depletion And Amortization $30.00K $40.00K $30.00K
YoY Change -40.0% 0.0% -50.0%
Cash From Operating Activities -$1.900M -$1.640M -$1.660M
YoY Change 14.46% -34.92% -27.51%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.930M -80.00K 1.710M
YoY Change 2135.48% -27.27% -1810.0%
NET CHANGE
Cash From Operating Activities -1.900M -1.640M -1.660M
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 6.930M -80.00K 1.710M
Net Change In Cash 5.030M -1.720M 50.00K
YoY Change -472.59% -34.6% -102.09%
FREE CASH FLOW
Cash From Operating Activities -$1.900M -$1.640M -$1.660M
Capital Expenditures $0.00
Free Cash Flow -$1.660M
YoY Change -27.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q2 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
1051821
CY2018Q4 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
832564
CY2019Q1 cur Additional Research And Development Expense Due To Modifications
AdditionalResearchAndDevelopmentExpenseDueToModifications
102000
cur Cost Reimbursements From Sbir Grant As Offset To Research And Development Expenses
CostReimbursementsFromSBIRGrantAsOffsetToResearchAndDevelopmentExpenses
280000
cur Cost Reimbursements From Sbir Grant As Offset To Research And Development Expenses
CostReimbursementsFromSBIRGrantAsOffsetToResearchAndDevelopmentExpenses
175000
CY2019Q2 cur Stock Issued During Period Value Rsu And Option Exercises Net Of Forfeitures
StockIssuedDuringPeriodValueRSUAndOptionExercisesNetOfForfeitures
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
128778
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
128778
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001357459
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2100291
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
Neuralstem, Inc.
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
cur
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
169905
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
294057
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3169
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-413
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
220125234
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
219654753
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
238835
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
196742
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
337966
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
196742
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
466744
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
435577
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2019Q2 us-gaap Assets
Assets
3521706
CY2018Q4 us-gaap Assets
Assets
7684450
CY2019Q2 us-gaap Assets Current
AssetsCurrent
2708099
CY2018Q4 us-gaap Assets Current
AssetsCurrent
6508393
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5787110
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6674940
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2281418
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7092832
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-3505692
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
417892
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1001798
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
910253
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1001798
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
910253
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
10018
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
9103
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1437934
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-628650
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4553669
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2775503
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-315
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2041
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P255D
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
171000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
us-gaap Depreciation And Amortization
DepreciationAndAmortization
77151
us-gaap Depreciation And Amortization
DepreciationAndAmortization
114312
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
96011
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1569049
CY2019Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
436126
CY2018Q2 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1378830
CY2019Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
487723
CY2018Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
583734
CY2019Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
CY2018Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
63938
CY2019Q2 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
CY2018Q4 us-gaap Due From Related Parties Noncurrent
DueFromRelatedPartiesNoncurrent
298238
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.45
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.83
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.78
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.67
us-gaap Interest Expense
InterestExpense
2524
us-gaap Interest Expense
InterestExpense
2692
us-gaap Interest Paid Net
InterestPaidNet
2524
us-gaap Interest Paid Net
InterestPaidNet
2692
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
10852
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
19514
us-gaap Investment Income Interest
InvestmentIncomeInterest
39852
us-gaap Investment Income Interest
InvestmentIncomeInterest
37263
CY2019Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1743
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3321
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
971822
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1260692
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1916424
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2442746
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
208472
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-151704
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-124152
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
165920
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-418625
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-362176
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-80959
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-56191
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
41690
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-41506
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-113406
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-43664
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
713265
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
763543
CY2019Q2 us-gaap Interest Expense
InterestExpense
507
CY2018Q2 us-gaap Interest Expense
InterestExpense
772
CY2019Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.1275
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
19800
CY2019Q2 us-gaap Liabilities
Liabilities
1559081
CY2018Q4 us-gaap Liabilities
Liabilities
1634900
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3521706
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7684450
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1071358
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1051166
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-195869
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-209636
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5000000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3309508
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4370431
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-2146968
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-627046
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3113992
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-1436921
us-gaap Net Income Loss
NetIncomeLoss
-4550913
us-gaap Net Income Loss
NetIncomeLoss
-2774014
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
481460
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1395926
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-175967
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1597953
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
1926275
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
2275472
us-gaap Operating Expenses
OperatingExpenses
4385340
us-gaap Operating Expenses
OperatingExpenses
4626967
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1918381
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2022972
us-gaap Operating Income Loss
OperatingIncomeLoss
-4374946
us-gaap Operating Income Loss
OperatingIncomeLoss
-4371967
us-gaap Operating Lease Payments
OperatingLeasePayments
59500
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
117900
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
108300
us-gaap Operating Leases Rent Expense Sublease Rentals1
OperatingLeasesRentExpenseSubleaseRentals1
27100
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
36901
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
23965
CY2018Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
115
CY2018Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1604
CY2019Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-1013
CY2019Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1013
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
10000
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
256776
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
363288
CY2018Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1604
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2756
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1489
CY2019Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
19537
CY2018Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
218602
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34989
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1646
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-309306
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5667
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
534809
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
1000000
CY2019Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
534809
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
1000000
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
5348
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
5000000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
63441
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
90311
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
195869
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
209636
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
954453
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1014780
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2468916
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2184221
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-218174806
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213623893
CY2019Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7894
CY2019Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
125481
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y255D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y182D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y36D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2018Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
252500
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
10394
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
255000
us-gaap Share Based Compensation
ShareBasedCompensation
466744
us-gaap Share Based Compensation
ShareBasedCompensation
435577
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
700000
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
98621
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
171.27
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2531
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
46379
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.61
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
81633
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
125481
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
136.85
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
215.60
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
323.42
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
8.53
CY2019Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
8515129
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
6607111
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
6175203
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
6049550
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
3271781
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1962625
us-gaap Sublease Income
SubleaseIncome
59100
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-size: 10pt; margin: 0pt 0"><div style="display: inline;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div> <div style=" font-size: 10pt; text-align: justify; margin: 0pt 0"><div style="display: inline;">The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The unaudited condensed consolidated financial statements include significant estimates for the expected economic life and value of our licensed technology and related patents, our net operating loss and related valuation allowance for tax purposes, the fair value of our liability classified warrants and our share-based compensation related to employees and directors, consultants and advisors, among other things. Because of the use of estimates inherent in the financial reporting process, actual results could differ significantly from those estimates.</div></div></div></div>
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
993854
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
757212
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
952567
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
756533

Files In Submission

Name View Source Status
0001171843-19-005480-index-headers.html Edgar Link pending
0001171843-19-005480-index.html Edgar Link pending
0001171843-19-005480.txt Edgar Link pending
0001171843-19-005480-xbrl.zip Edgar Link pending
cur-20190630.xml Edgar Link completed
cur-20190630.xsd Edgar Link pending
cur-20190630_cal.xml Edgar Link unprocessable
cur-20190630_def.xml Edgar Link unprocessable
cur-20190630_lab.xml Edgar Link unprocessable
cur-20190630_pre.xml Edgar Link unprocessable
exh_311.htm Edgar Link pending
exh_321.htm Edgar Link pending
f10q_081319p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending